focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVenn Life Sciences Share News (VENN)

  • There is currently no data for VENN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rightmove Chairman sells 7m pounds of shares

Tue, 27th May 2014 15:09

Rightmove's Chairman Scott Forbes has offloaded nearly a half of a holding in the property website group, selling over seven million pounds in shares.Forbes, who has been in his current role since 2005, sold 300,000 shares at an average price of 2,350.81p each, raising a total of £7.05m.Following the deal, his holding was reduced to 319,300 shares, representing a 0.3221% stake in the company.Rightmove said earlier this month that it had made a "positive start" to 2014 as audience continued to grow with page impressions up 14% in the first four months of the year.Meanwhile, the company generated a record 14.8m enquiries for its customers, up 30% on the year, while average revenues per advertiser showed "healthy growth".The business has been boosted over the past year by the recent boom in the UK housing market. However, competition has increased in recent months with rival firm Zoopla announcing its intention to float in June and another property portal called Agent Mutual due to launch next January.Rightmove's shares have fallen by around 15% in the year-to-date but have still risen by nearly 500% since the stock first listed in 2006.Top Director BuysEveryman Media Group (EMAN) Director name: Mr Adam KayeAmount purchased: 207,409 @ 89.00p Value: £184,594REA Holdings (RE.) Director name: Mr David BlackettAmount purchased: 10,000 @ 470.00p Value: £47,000Venn Life Sciences Holdings (VENN) Director name: Mr David Eric EvansAmount purchased: 210,000 @ 20.50p Value: £43,050Dunedin Enterprise Investment Trust (DNE) Director name: Mr Brian FinlaysonAmount purchased: 6,600 @ 429.78p Value: £28,365Wolf Minerals Limited (WLFE) Director name: Mr Russell Clark Amount purchased: 83,333 @ 30.00p Value: £25,000Kea Petroleum (KEA) Director name: Mr Ian Roderick Gowrie-SmithAmount purchased: 865,140 @ 1.95p Value: £16,870NWF Group (NWF) Director name: Mr Philip ActonAmount purchased: 10,000 @ 155.00p Value: £15,500Laird (LRD) Director name: Mr David LockwoodAmount purchased: 4,163 @ 283.59p Value: £11,806Top Director SellsRightmove (RMV) Director name: Mr Scott ForbesAmount sold: 300,000 @ 2,350.81p Value: £7,052,430Grafton Group Units (GFTU) Director name: Mr Gavin SlarkAmount sold: 41,700 @ 585.00p Value: £243,945Hansa Trust 'A' Non Voting Shares (HANA) Director name: Professor Geoffrey WoodAmount sold: 6,500 @ 960.00p Value: £62,400Hansa Trust (HAN) Director name: Professor Geoffrey WoodAmount sold: 5,000 @ 952.00p Value: £47,600Dunedin Enterprise Investment Trust (DNE) Director name: Mr Brian FinlaysonAmount sold: 5,975 @ 475.00p Value: £28,381BC
More News
23 Oct 2015 08:17

Venn Life Sciences signs EUR1m contract

(ShareCast News) - Venn Life Sciences has signed a €1m contract with a leading French biotech company. The AIM listed clinical research organisation announced the deal on Friday. The two-phase project is centred on acute T-cell leukaemia, and will cover multiple regions including France, the UK and

Read more
23 Oct 2015 06:42

Venn Life Sciences Wins Leukaemia Project Worth Over EUR1 Million

Read more
19 Oct 2015 07:12

Venn Life Sciences Appoints Kinesis Pharma's Groen Executive Director

Read more
22 Sep 2015 15:51

Venn Life posts narrow interim loss, acquires Kinesis

(ShareCast News) - Clinical trial services provider Venn Life Sciences posted a narrower interim pre-tax loss and has agreed to acquire Kinesis Pharma BV. In the six months to the end of June, the London-listed company saw its pre-tax loss narrow from €987,000 (£716,000) to €259,000, while revenue a

Read more
22 Sep 2015 08:35

Venn Life Sciences To Buy Kinesis Pharma As Interim Loss Narrows (ALLISS)

Read more
13 Aug 2015 11:35

Venn Life Sciences reports strong first-half trading

(ShareCast News) - Venn Life sciences said it has had a strong first half, with revenues up 170% on the previous year. In a very brief trading update, the company, which provides clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, reported

Read more
13 Aug 2015 06:45

Venn Life Sciences Says Strong First Half Driven By Contract Wins

Read more
30 Jun 2015 08:31

Venn Life Sciences Sees "Further Solid Trading" In First Half

Read more
30 Jun 2015 07:31

LONDON BRIEFING: Shares Ignore Positive Asian Session To Open Lower

Read more
30 Jun 2015 05:16

AGM, EGM Calendar - Week Ahead

Read more
29 Jun 2015 15:11

AGM, EGM Calendar - Week Ahead

Read more
29 Jun 2015 05:21

AGM, EGM Calendar - Week Ahead

Read more
26 Jun 2015 15:13

AGM, EGM Calendar - Week Ahead

Read more
26 Jun 2015 05:20

AGM, EGM Calendar - Week Ahead

Read more
25 Jun 2015 15:30

AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.